Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol
about
Metabolomics reveals amino acids contribute to variation in response to simvastatin treatmentAllopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathyIs lipid signaling through cannabinoid 2 receptors part of a protective system?Nitric oxide and peroxynitrite in health and diseaseThe endocannabinoid system as an emerging target of pharmacotherapyCardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative StressNSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesAre either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisalInterplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathyMechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and goutSubstrate orientation in xanthine oxidase: crystal structure of enzyme in reaction with 2-hydroxy-6-methylpurineSubstrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase: CRYSTAL STRUCTURES IN COMPLEX WITH XANTHINE AND LUMAZINETargeting TRPM2 in ROS-Coupled DiseasesOxidative Stress during HIV Infection: Mechanisms and ConsequencesCancer cachexia: impact, mechanisms and emerging treatmentsReactive oxygen species in inflammation and tissue injuryFlavonoid glycosides isolated from unique legume plant extracts as novel inhibitors of xanthine oxidaseEicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexiaIntegrating cellular metabolism into a multiscale whole-body modelChronic allopurinol treatment during the last trimester of pregnancy in sows: effects on low and normal birth weight offspringRole of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method.The Chemistry of Neurodegeneration: Kinetic Data and Their Implications.Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data.Effect of allopurinol on blood pressure: a systematic review and meta-analysis.Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in miceUric acid as one of the important factors in multifactorial disorders--facts and controversies.Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload.Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage.Uric acid promotes an acute inflammatory response to sterile cell death in miceUric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.Febuxostat: the evidence for its use in the treatment of hyperuricemia and goutHypoxic ischemic brain injury: Potential therapeutic interventions for the future.Prevention effect of allopurinol on post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of prospective randomized controlled trials.Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel.Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}
P2860
Q21561017-C26360FE-5471-47A0-BEF8-D01C06BBDA44Q24202191-6A1F2919-8AF2-4CDB-B392-FDF7B0B8C1B7Q24633122-8243EF25-709F-4BA3-B1DB-B8A187D16ACBQ24645400-69B5B016-A614-4CFD-B5AA-EBE0706BB481Q24648473-46335497-A457-4E39-971C-C6A7B3D30847Q26773004-851F7CF6-6D28-4C12-A505-F0F4D3F34496Q26784322-A4A3F4B4-67A2-4CC9-8865-88127B9D24ADQ26862468-859F2DDB-B6E6-46B0-B35B-262947A2C0C1Q27001165-6CBE0631-57A0-4D83-8D16-F65DA00911FDQ27023909-FA7AAF8D-9424-4F61-8F5D-EE91FBB5CCFCQ27649230-F654D9D4-99F1-44F6-B781-5220DF1E017CQ27653276-9341F035-A47E-48A5-ABFE-4D33F0931FE3Q28067161-7FCE877E-63AC-4D49-9272-26F0D101A103Q28077167-F39BEF67-9143-4151-A343-D471513B59A5Q28384479-A583280C-8818-4E82-8F53-C29B75840167Q28396273-F475032F-0083-474C-8F55-DF5A5220D5AAQ28481361-FEB9258E-9A59-4AEB-96A8-F3DB2B2FE1E2Q28483912-F9346014-74C2-4682-9D3E-0006E6E3E328Q28484829-0189C4AB-5D16-4490-97DA-401392D43C20Q28539019-2DCEF804-F501-4C39-99AA-F16085786C62Q30455065-FCDD90C0-7255-4AA6-B91C-770D06D0FA2DQ30973484-28656A75-8C3E-46B7-9BD3-736C0B2370FCQ31095161-06F9E656-FC02-490D-A275-E42AB260E941Q31118679-C88D4B77-65B4-4BBB-8202-467DC7D9CCEDQ33643575-B8AD4D9F-D029-4F43-856D-DFF21AEF623EQ33683082-F0FFCB98-D40D-40E9-9D9C-C45710DCFCECQ33773142-6AF9E510-1B8C-4A23-BA5E-76404088EB5CQ33816822-8C186C58-745A-410B-A17F-9444B46BC722Q33873720-73067CD3-A244-4341-BFCB-2164D1DB6828Q33882855-E7E21D5C-3A46-45CA-81FD-C7D2AB8B6B19Q33890860-D118AC4B-E634-437C-9F0A-A48C3EDCB902Q33973851-BEFAB7B2-DE03-421F-83AA-4DC7D68D9732Q34106605-E67B2D46-61DF-4E16-8AF6-16D57216A922Q34156180-6D2D83ED-B692-43D0-907E-D0C5CB647E0FQ34204033-D4A63290-8369-4544-B7EE-320EBAE0E980Q34351848-8489F675-A22B-49BA-BF5C-1B0135E4A921Q34396286-F2A331F5-1AF2-4DDD-B246-1E0D5729D8B8Q34398552-85536B60-E811-4D11-9824-57395B518BFFQ34447034-39A743A3-3471-489F-9787-6C5449AC08CEQ34489192-A715258F-5289-4DC7-84D0-40EE982FF514
P2860
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@ast
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@en
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@nl
type
label
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@ast
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@en
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@nl
prefLabel
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@ast
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@en
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@nl
P2860
P3181
P356
P1476
Therapeutic effects of xanthin ...... r the discovery of allopurinol
@en
P2093
Alex Nivorozhkin
Csaba Szabó
P2860
P304
P3181
P356
10.1124/PR.58.1.6
P407
P50
P577
2006-03-01T00:00:00Z